JP2022504707A5 - - Google Patents
Info
- Publication number
- JP2022504707A5 JP2022504707A5 JP2021519840A JP2021519840A JP2022504707A5 JP 2022504707 A5 JP2022504707 A5 JP 2022504707A5 JP 2021519840 A JP2021519840 A JP 2021519840A JP 2021519840 A JP2021519840 A JP 2021519840A JP 2022504707 A5 JP2022504707 A5 JP 2022504707A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- atoms
- double bonds
- heteroatoms
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024073580A JP2024122966A (ja) | 2018-10-11 | 2024-04-30 | 芳香族化合物およびその医薬用途 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862744461P | 2018-10-11 | 2018-10-11 | |
| US62/744,461 | 2018-10-11 | ||
| PCT/IB2019/001139 WO2020074964A1 (en) | 2018-10-11 | 2019-10-10 | Romatic compounds and pharmaceutical uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024073580A Division JP2024122966A (ja) | 2018-10-11 | 2024-04-30 | 芳香族化合物およびその医薬用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022504707A JP2022504707A (ja) | 2022-01-13 |
| JP2022504707A5 true JP2022504707A5 (enExample) | 2022-10-18 |
Family
ID=68655570
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021519840A Pending JP2022504707A (ja) | 2018-10-11 | 2019-10-10 | 芳香族化合物およびその医薬用途 |
| JP2024073580A Pending JP2024122966A (ja) | 2018-10-11 | 2024-04-30 | 芳香族化合物およびその医薬用途 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024073580A Pending JP2024122966A (ja) | 2018-10-11 | 2024-04-30 | 芳香族化合物およびその医薬用途 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US12473249B2 (enExample) |
| EP (1) | EP3864001A1 (enExample) |
| JP (2) | JP2022504707A (enExample) |
| KR (1) | KR20210091150A (enExample) |
| CN (2) | CN113166024B (enExample) |
| AU (2) | AU2019358595B2 (enExample) |
| CA (1) | CA3112073A1 (enExample) |
| CL (1) | CL2021000846A1 (enExample) |
| CO (1) | CO2021006087A2 (enExample) |
| EA (1) | EA202190890A1 (enExample) |
| IL (1) | IL282134A (enExample) |
| MA (1) | MA53188A1 (enExample) |
| MX (1) | MX2021003750A (enExample) |
| PH (1) | PH12021550744A1 (enExample) |
| SG (1) | SG11202103011YA (enExample) |
| WO (1) | WO2020074964A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023065200A1 (en) * | 2021-10-21 | 2023-04-27 | Givaudan Sa | Organic compounds |
| WO2024206117A1 (en) | 2023-03-24 | 2024-10-03 | Northsea Therapeutics B.V. | Benzoic acid derivatives for use in methods of treating intestinal failure-associated liver disease in children |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5210266A (en) * | 1987-12-03 | 1993-05-11 | Dainippon Pharmaceutical Co., Ltd. | N-substituted mercaptopropanamide derivatives |
| EP0637957B1 (de) | 1992-04-28 | 1997-07-23 | Fresenius AG | Verwendung einer omega-3-fettsäuren enthaltenden emulsion zur herstellung eines parenteral zu verabreichenden arzneimittels zur behandlung von entzündlichen erkrankungen |
| DK1900364T3 (da) | 2001-04-18 | 2014-01-13 | Prometic Biosciences Inc | Fedtsyrer, glycerider og analoger med medium kædelængde som neutrofile overlevelses- og aktiveringsfaktorer |
| RU2341513C2 (ru) * | 2001-06-12 | 2008-12-20 | Веллстат Терапьютикс Корпорейшн | Соединения для лечения метаболических заболеваний |
| US7553867B2 (en) | 2002-09-06 | 2009-06-30 | Takeda Pharmaceutical Company Limited | Furan or thiophene derivative and medicinal use thereof |
| WO2006066894A1 (en) | 2004-12-24 | 2006-06-29 | Ctg Pharma S.R.L. | Compounds for treating metabolic syndrome |
| AU2004210082B2 (en) * | 2003-02-06 | 2011-03-17 | Dompe' Farmaceutici S.P.A. | 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them |
| BRPI0407276A (pt) | 2003-02-07 | 2006-01-31 | Prometic Biosciences Inc | ácidos graxos, glicerìdeos e análogos com comprimento de cadeia médio, como estimulantes de eritropoiese |
| ES2530235T3 (es) * | 2003-02-13 | 2015-02-27 | Wellstat Therapeutics Corporation | Compuestos para el tratamiento de trastornos metabólicos |
| PL1648851T3 (pl) | 2003-07-25 | 2007-09-28 | Prometic Biosciences Inc | Wytwarzanie soli średniołańcuchowych kwasów tłuszczowych z metalami |
| ES2372694T3 (es) * | 2003-10-15 | 2012-01-25 | OSI Pharmaceuticals, LLC | Inhibidores de tirosina cinasa de imidazo[1,5-a]pirazina. |
| US20070111989A1 (en) | 2003-12-05 | 2007-05-17 | Olivier Bezencon | Novel diazabicyclononene derivatives and use |
| AP2007003939A0 (en) | 2004-09-03 | 2007-04-30 | Prometic Biosciences Inc | Substituted purinyl derivatives with immunomodulator and chemoprotective activity and use alone or with medium-chain length fatty acids or glycerides |
| US8071580B2 (en) | 2004-10-01 | 2011-12-06 | Prometic Biosciences Inc. | Medium-chain length fatty alcohols as stimulators of hematopoiesis |
| EA200700741A1 (ru) | 2004-10-01 | 2007-08-31 | Прометик Байосайенсиз Инк. | Жирные спирты со средней длиной цепи как стимуляторы гематопоэза |
| TW200724138A (en) * | 2005-03-29 | 2007-07-01 | Sk Corp | Substituted carboxylic acid derivatives for the treatment of diabetes and lipid disorders, their preparation and use |
| CN101218199A (zh) | 2005-05-09 | 2008-07-09 | 阿斯利康(瑞典)有限公司 | 新化合物ⅰ |
| GB0522433D0 (en) | 2005-11-03 | 2005-12-14 | Astrazeneca Ab | Therapeutic agents |
| RU2008136898A (ru) | 2006-02-15 | 2010-03-20 | Санофи-Авентис (Fr) | Азациклил-замещенные арилдигидроизохинолиноны, способ их получения и их применение в качестве лекарственных средств |
| WO2008016007A1 (fr) | 2006-07-31 | 2008-02-07 | Meiji Seika Kaisha, Ltd. | INHIBITEUR DE LA MÉTALLO-β-LACTAMASE |
| JP5526018B2 (ja) * | 2007-03-21 | 2014-06-18 | エミスフェアー・テクノロジーズ・インク | アリルオキシおよびアルキルオキシ安息香酸送達薬剤 |
| WO2008151211A1 (en) * | 2007-06-05 | 2008-12-11 | Sanofi-Aventis | Substituted benzoylamino-indan-2-carboxylic acids and related compounds |
| US9532962B2 (en) | 2007-11-02 | 2017-01-03 | Prometic Pharma Smt Limited | Medium-chain length fatty acids and glycerides as nephroprotection agents |
| JP5473937B2 (ja) | 2007-12-19 | 2014-04-16 | プロメティック・バイオサイエンシーズ・インコーポレイテッド | 膵臓癌の治療のためのゲムシタビンと併用した中鎖脂肪酸、その塩およびトリグリセリド |
| KR20100135793A (ko) * | 2008-03-13 | 2010-12-27 | 바스프 에스이 | 이량체 벤질리덴 말로네이트 |
| CN102088965B (zh) | 2008-05-13 | 2013-05-08 | 根梅迪卡治疗公司 | 水杨酸盐(酯)缀合物在制备用于治疗代谢性病症的药物中的应用 |
| JP2012503595A (ja) * | 2008-07-28 | 2012-02-09 | シダンスク ユニバーシティ | 代謝病の治療用の化合物 |
| EP2427416B1 (en) | 2009-05-04 | 2016-03-09 | Prometic Pharma Smt Limited | Substituted aromatic compounds and pharmaceutical uses thereof |
| KR101783817B1 (ko) * | 2009-05-08 | 2017-10-23 | 프로노바 바이오파마 너지 에이에스 | 심혈관 질병, 대사 질병, 및 염증성 질환 분야관련 질병의 치료를 위한 다중 불포화 지방산 |
| EA022120B1 (ru) * | 2009-10-20 | 2015-11-30 | Целльзом Лимитид | Аналоги гетероциклил пиразолопиримидина в качестве ингибиторов jak |
| ES2441665T3 (es) | 2009-11-26 | 2014-02-05 | Genfit | Utilización de derivados de 1,3-difenilprop-2-en-1-ona para tratar trastornos hepáticos |
| TWI572352B (zh) | 2012-03-01 | 2017-03-01 | 波麥堤克藥學Ｓｍｔ有限公司 | 用於製備具中鏈長度之脂肪酸的三酸甘油酯之方法 |
| US9562041B2 (en) * | 2012-05-16 | 2017-02-07 | Glaxosmithkline Llc | Enhancer of zeste homolog 2 inhibitors |
| TWI689490B (zh) | 2013-03-15 | 2020-04-01 | 英商邊緣生物科技有限公司 | 用於治療纖維化之經取代之芳族化合物及相關方法 |
| TWI742541B (zh) | 2013-03-15 | 2021-10-11 | 英商邊緣生物科技有限公司 | 用於治療肺纖維化、肝纖維化、皮膚纖維化及心臟纖維化之經取代之芳族化合物 |
| WO2015179697A1 (en) | 2014-05-21 | 2015-11-26 | Taxis Pharmaceuticals, Inc. | Compounds for the treatment of bacterial infections |
| SG11201702812PA (en) | 2014-10-10 | 2017-05-30 | Prometic Pharma Smt Ltd | Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of diabetes |
| GB2543478A (en) | 2015-09-07 | 2017-04-26 | Manchester Metropolitan Univ | Glycomimetics |
| KR102793841B1 (ko) | 2018-05-08 | 2025-04-11 | 가부시키가이샤 아데카 | 화합물, 잠재성 첨가제, 조성물, 경화물, 경화물의 제조 방법 및 조성물의 제조 방법 |
-
2019
- 2019-10-10 MA MA53188A patent/MA53188A1/fr unknown
- 2019-10-10 US US17/284,022 patent/US12473249B2/en active Active
- 2019-10-10 JP JP2021519840A patent/JP2022504707A/ja active Pending
- 2019-10-10 CA CA3112073A patent/CA3112073A1/en active Pending
- 2019-10-10 MX MX2021003750A patent/MX2021003750A/es unknown
- 2019-10-10 CN CN201980067283.2A patent/CN113166024B/zh active Active
- 2019-10-10 SG SG11202103011YA patent/SG11202103011YA/en unknown
- 2019-10-10 EP EP19809143.1A patent/EP3864001A1/en active Pending
- 2019-10-10 AU AU2019358595A patent/AU2019358595B2/en active Active
- 2019-10-10 WO PCT/IB2019/001139 patent/WO2020074964A1/en not_active Ceased
- 2019-10-10 KR KR1020217014095A patent/KR20210091150A/ko active Pending
- 2019-10-10 EA EA202190890A patent/EA202190890A1/ru unknown
- 2019-10-10 CN CN202510894488.5A patent/CN120923343A/zh active Pending
-
2021
- 2021-04-05 PH PH12021550744A patent/PH12021550744A1/en unknown
- 2021-04-05 CL CL2021000846A patent/CL2021000846A1/es unknown
- 2021-04-07 IL IL282134A patent/IL282134A/en unknown
- 2021-05-11 CO CONC2021/0006087A patent/CO2021006087A2/es unknown
-
2024
- 2024-04-30 JP JP2024073580A patent/JP2024122966A/ja active Pending
-
2025
- 2025-07-16 AU AU2025205518A patent/AU2025205518A1/en active Pending
- 2025-10-24 US US19/368,054 patent/US20260184664A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2302825T3 (es) | Derivados de acido indano acetico y su uso como agentes farmaceuticos, intermedios, y procedimiento de preparacion. | |
| JP6371312B2 (ja) | 坑炎症および抗腫瘍２−オキソチアゾール化合物ならびに２−オキソチオフェン化合物 | |
| CN102036946A (zh) | 用于治疗疼痛的度洛西汀和Cox-抑制剂的共晶体 | |
| JP2023552699A5 (enExample) | ||
| TW201039815A (en) | Compositions and methods for the treatment of inflammation | |
| JP2023513901A5 (enExample) | ||
| JP5073708B2 (ja) | 細胞損傷及び炎症疾患の治療または予防用薬学組成物 | |
| JP2015522617A (ja) | タンパク質凝集の阻害剤としてのジ−およびトリ−ヘテロアリール誘導体 | |
| CN111801013A (zh) | 小分子核受体调节剂的酰胺前药 | |
| CN102093246A (zh) | 酯类化合物、其制备方法和应用 | |
| JP5751168B2 (ja) | 線維筋痛症の治療剤又は予防剤 | |
| JP2008507498A (ja) | アルツハイマー病の治療のためのアリール酢酸および関連化合物 | |
| JP2018515463A5 (enExample) | ||
| JP2021522327A5 (enExample) | ||
| JP4832897B2 (ja) | エステル誘導体及びその医薬用途 | |
| JP2024122966A (ja) | 芳香族化合物およびその医薬用途 | |
| US9527852B2 (en) | Phenyl-urea and phenyl-carbamate derivatives as inhibitors of protein aggregation | |
| JP2017511340A (ja) | ヒストンアセチルトランスフェラーゼ活性剤及びその使用 | |
| JOP20230072A1 (ar) | تحضير مشتقات بنزيميدازولون كمثبطات داي أسيل جليسريد o -أسيل ترانسفيراز 2 جديدة | |
| JP5682555B2 (ja) | アルツハイマー病の治療剤又は予防剤 | |
| JP2018510206A5 (enExample) | ||
| WO2012145899A1 (zh) | 酯类化合物、其制备方法和应用 | |
| CN102190632B (zh) | 2,4,5-三取代硒唑类化合物及其制备方法、组合物和用途 | |
| WO2010034212A1 (zh) | 苯氧乙酸吡嗪酯类衍生物及其制法和用途 | |
| TW200946105A (en) | Therapeutic agent or preventive agent for inflammatory bowel disease containing amino alcohol derivative as active ingredient |